- Home
- IGIC vs RCKT Comparison
IGIC vs RCKT Comparison
Compare IGIC & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGIC
- RCKT
- Stock Information
- Founded
- IGIC 2001
- RCKT 1999
- Country
- IGIC Jordan
- RCKT United States
- Employees
- IGIC N/A
- RCKT N/A
- Industry
- IGIC Property-Casualty Insurers
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- IGIC Finance
- RCKT Health Care
- Exchange
- IGIC Nasdaq
- RCKT Nasdaq
- Market Cap
- IGIC 1.0B
- RCKT 1.1B
- IPO Year
- IGIC N/A
- RCKT N/A
- Fundamental
- Price
- IGIC $24.87
- RCKT $8.50
- Analyst Decision
- IGIC Buy
- RCKT Strong Buy
- Analyst Count
- IGIC 2
- RCKT 10
- Target Price
- IGIC $31.50
- RCKT $44.10
- AVG Volume (30 Days)
- IGIC 85.1K
- RCKT 1.3M
- Earning Date
- IGIC 05-06-2025
- RCKT 05-05-2025
- Dividend Yield
- IGIC 0.40%
- RCKT N/A
- EPS Growth
- IGIC 16.99
- RCKT N/A
- EPS
- IGIC 2.98
- RCKT N/A
- Revenue
- IGIC $539,000,000.00
- RCKT N/A
- Revenue This Year
- IGIC N/A
- RCKT N/A
- Revenue Next Year
- IGIC $6.00
- RCKT $307.50
- P/E Ratio
- IGIC $8.54
- RCKT N/A
- Revenue Growth
- IGIC 7.95
- RCKT N/A
- 52 Week Low
- IGIC $12.73
- RCKT $8.06
- 52 Week High
- IGIC $27.76
- RCKT $28.73
- Technical
- Relative Strength Index (RSI)
- IGIC 45.48
- RCKT 36.68
- Support Level
- IGIC $23.78
- RCKT $8.06
- Resistance Level
- IGIC $25.69
- RCKT $8.91
- Average True Range (ATR)
- IGIC 1.13
- RCKT 0.57
- MACD
- IGIC -0.13
- RCKT -0.05
- Stochastic Oscillator
- IGIC 27.39
- RCKT 17.19
About IGIC International General Insurance Holdings Ltd.
International General Insurance Holdings Ltd is an international specialist commercial insurer and a reinsurer, underwriting a diverse portfolio of specialty lines. The company operates in a portfolio of Energy, Property, Construction, Engineering, Ports and terminals, Financial Institutions, General Aviation, Professional Indemnity, Casualty, Directors and Officers, Political Violence, Forestry, and Treaty Reinsurance. Its operating segment includes Specialty Longtail; Specialty Short tail and Reinsurance.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.